1

northeastern_university_logo

06.23.2020

Related Articles

Global Pharma Market Access: Pharmacoeconomics in Middle-income Countries

Many middle-income countries such as Egypt, South Africa, Malaysia, Thailand, and Brazil have pharmacoeconomic guidelines. These follow the recommendations by the International Society for Pharmacoeconomics and Outcomes Research but include country-specific differences. The variations respond to changes in how governments apply pharmacoeconomics and determine market access to pharmaceuticals and medical devices. This is also determined […]

Read all
Budget Impact Analysis

What is Budget Impact Analysis? Pharmacoeconomic analyses in healthcare are paramount, because of the high costs of innovative technologies and limited possibilities of their funding. Budget Impact Analysis (BIA) is one such analysis that provides vital information for healthcare decision makers [1].  Unlike economic evaluations, such as cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and cost-benefit […]

Read all
The Pharma Market Access Landscape in the Middle East and North Africa: The Next Ten Years

Introduction The market access landscape in the Middle East and North Africa is changing rapidly. The region is diverse, comprises many dissimilar countries, and different cultures including languages used in commerce. There are also different approaches to regulating healthcare markets, and concerns about the long-term sustainability of oil revenues shape healthcare markets. There are other […]

Read all
Read all articles